BioSpace News Archive

Drug Development

New HER-Vaxx Cancer Vaccine trial data presented at the European Society of Medical Oncology World Congress on Gastrointestinal Cancer

Imugene Limited, a clinical stage immuno-oncology company, announced new clinical data from the Phase Ib study of its HER-Vaxx cancer vaccine showing cancer fighting antibody and clinical response rates continue to be positive in the patients receiving the optimal biological dose of vaccine.

July 8, 2019
·
4 min read
The Medication Adherence Expertise Center at the University of Groningen in the Netherlands links up with Elucid on final development of an advanced smart pill bottle to monitor patient adherence

Second clinical trial of Pill Connect system to be undertaken through University of Groningen following successful trial of prototypes with major CRO

July 8, 2019
·
4 min read
Policy

Bellicum Pharmaceuticals Announces Rivo-cel™ Achieves Primary Endpoint in Pediatric Registrational Trial

Primary endpoint of event free survival (EFS) rate at 180 days of 90.9 percent reported for rivo‑cel in BP-004 European registrational trial

July 8, 2019
·
7 min read
Business

Simbec-Orion Announce Its New Unified Brand Offering

Simbec-Orion, Europe’s leading full-service boutique CRO, announces its new unified brand offering comprising the divisions previously known as Simbec Research, Orion Clinical, Orion Santé and Seirian Laboratories.

July 8, 2019
·
2 min read
Business

MorphoSys and Vivoryon Therapeutics Enter Agreement on Small Molecule Inhibitors of CD47-SIRP alpha Signaling in Immuno-Oncology

Vivoryon Therapeutics AG and MorphoSys AG today announced that they have entered into an agreement under the terms of which MorphoSys has obtained an exclusive option to license Vivoryon’s small molecule QPCTL inhibitors in the field of oncology.

July 8, 2019
·
8 min read
Business

Acer Therapeutics Restructures Company, Eliminates 29 Employees Following FDA’s CRL

In addition to the layoffs, Acer said it has halted pre-commercial activities surrounding Edsivo due to the FDA’s rejection last month.

July 8, 2019
·
2 min read
·
Alex Keown
Business

Skyhawk Therapeutics Partners with Merck to Discover and Develop RNA-Binding Molecules

Skyhawk and Merck will partner to discover and develop innovative RNA-binding small molecules that can form treatments for neurological diseases and cancer.

July 8, 2019
·
2 min read
·
Alex Keown
Business

China’s Pharmaceutical Market Expected to Boom In Coming Years

“I believe the next Google-level company in healthcare could come from China,” stated Jackson Zhu Weiyan, chief executive officer and founder of My Bio-Med. “China is truly embracing innovation.”

July 8, 2019
·
4 min read
·
Mark Terry
Policy

Acacia Pharma Plans to Resubmit the BARHEMSYS® NDA in Q3 2019

This announcement contains inside information for the purposes of Article 7 of the Market Abuse Regulation (EU) No 596/2014.

July 8, 2019
·
4 min read
Business

NeoPhore appoints Dr Matthew Baker as VP Immunology

NeoPhore Limited, a small molecule cancer immuno-oncology company, announces the appointment of Dr Matthew Baker as VP Immunology to the company’s management team.

July 8, 2019
·
2 min read